A U.S. congressional committee has demanded that former drug executive Martin Shkreli appear at a hearing on drug prices to testify about his former company’s decision to raise the price of a lifesaving drug by more than 5,000 percent, congressional aides said on Wednesday. Shkreli, who is sep...